Impact of Adjuvant Chemotherapy on Patients with Lymph Node-Positive Esophageal Cancer who are primarily Treated with Surgery.

Katrin M Sjoquist, Bryan H Burmeister, B Mark Smithers, John R Zalcberg, R John Simes, Andrew Barbour, Val Gebski, Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis Lancet Oncology. ,vol. 12, pp. 681- 692 ,(2011) , 10.1016/S1470-2045(11)70142-5

Nobutoshi Ando, Toshifumi Iizuka, Hiroko Ide, Kaoru Ishida, Masayuki Shinoda, Tadashi Nishimaki, Wataru Takiyama, Hiroshi Watanabe, Kaichi Isono, Norio Aoyama, Hiroyasu Makuuchi, Otsuo Tanaka, Hideaki Yamana, Shunji Ikeuchi, Toshiyuki Kabuto, Kagami Nagai, Yutaka Shimada, Yoshihide Kinjo, Haruhiko Fukuda, Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204. Journal of Clinical Oncology. ,vol. 21, pp. 4592- 4596 ,(2003) , 10.1200/JCO.2003.12.095

Christophe Mariette, Guillaume Piessen, Jean-Pierre Triboulet, Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncology. ,vol. 8, pp. 545- 553 ,(2007) , 10.1016/S1470-2045(07)70172-9

Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial The Lancet. ,vol. 359, pp. 1727- 1733 ,(2002) , 10.1016/S0140-6736(02)08651-8

Mary Armanios, Ronghui Xu, Arlene A. Forastiere, Daniel G. Haller, John W. Kugler, Al B. Benson, Adjuvant Chemotherapy for Resected Adenocarcinoma of the Esophagus, Gastro-Esophageal Junction, and Cardia: Phase II Trial (E8296) of the Eastern Cooperative Oncology Group Journal of Clinical Oncology. ,vol. 22, pp. 4495- 4499 ,(2004) , 10.1200/JCO.2004.06.533

Christophe Mariette, Laetitia Dahan, Françoise Mornex, Emilie Maillard, Pascal-Alexandre Thomas, Bernard Meunier, Valérie Boige, Denis Pezet, William B. Robb, Valérie Le Brun-Ly, Jean-François Bosset, Jean-Yves Mabrut, Jean-Pierre Triboulet, Laurent Bedenne, Jean-François Seitz, Surgery Alone Versus Chemoradiotherapy Followed by Surgery for Stage I and II Esophageal Cancer: Final Analysis of Randomized Controlled Phase III Trial FFCD 9901 Journal of Clinical Oncology. ,vol. 32, pp. 2416- 2422 ,(2014) , 10.1200/JCO.2013.53.6532

Masaki Arimori, Kaoru Ishida, Shoichiro Tsugane, A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: The Japan clinical oncology group study The Journal of Thoracic and Cardiovascular Surgery. ,vol. 114, pp. 205- 209 ,(1997) , 10.1016/S0022-5223(97)70146-6

H.L. van Westreenen, M. Westerterp, P.M.M. Bossuyt, J. Pruim, G.W. Sloof, J.J.B. van Lanschot, H. Groen, J.Th.M. Plukker, Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer Journal of Clinical Oncology. ,vol. 22, pp. 3805- 3812 ,(2004) , 10.1200/JCO.2004.01.083

H. L. van Westreenen, M. Westerterp, G. W. Sloof, H. Groen, P. M. M. Bossuyt, P. L. Jager, E. F. Comans, H. M. van Dullemen, P. Fockens, J. Stoker, E. J. van der Jagt, J. J. B. van Lanschot, J. T. M. Plukker, Limited additional value of positron emission tomography in staging oesophageal cancer British Journal of Surgery. ,vol. 94, pp. 1515- 1520 ,(2007) , 10.1002/BJS.5708

Pieter van Hagen, MCCM Hulshof, JJB Van Lanschot, EW Steyerberg, MI Van Berge Henegouwen, BPL Wijnhoven, DJ Richel, GAP Nieuwenhuijzen, GAP Hospers, JJ Bonenkamp, MA Cuesta, RJB Blaisse, ORC Busch, FJW Ten Kate, G-J Creemers, CJA Punt, J Th M Plukker, HMW Verheul, EJ Spillenaar Bilgen, Herman van Dekken, MJC Van Der Sangen, Tom Rozema, Katharina Biermann, JC Beukema, AHM Piet, CM Van Rij, JG Reinders, HW Tilanus, Ate van der Gaast, None, Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer The New England Journal of Medicine. ,vol. 366, pp. 2074- 2084 ,(2012) , 10.1056/NEJMOA1112088